Gallman Cari bought BMY
October 2, 2026 · Form 4 insider transaction
Gallman Cari bought 4,559 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,559
Price
$0.00
Total value
N/A
InsiderGallman Cari
Role—
SecurityCommon Stock, $0.10 par value
Transaction codeM: Option exercise
Transaction dateOctober 2, 2026
Filing dateOctober 5, 2026
Shares owned after18,208
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted stock units vested in three equal installments beginning on October 2, 2024.